CYTH
Cyclo Therapeutics Inc - Ordinary Shares - Class A

6,140
Mkt Cap
$20.62M
Volume
188,267.00
52W High
$1.62
52W Low
$0.55
PE Ratio
-0.81
CYTH Fundamentals
Price
$0.7206
Prev Close
$0.7107
Open
$0.661
50D MA
$0.7809
Beta
0.80
Avg. Volume
51,015.57
EPS (Annual)
-$0.8101
P/B
-1.54
Loading...
Loading...
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Cyclo Therapeutics Inc - Ordinary Shares - Class A?
What is the 52-week high for Cyclo Therapeutics Inc - Ordinary Shares - Class A?
What is the 52-week low for Cyclo Therapeutics Inc - Ordinary Shares - Class A?
What is Cyclo Therapeutics Inc - Ordinary Shares - Class A stock price today?
What was Cyclo Therapeutics Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Cyclo Therapeutics Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Cyclo Therapeutics Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Cyclo Therapeutics Inc - Ordinary Shares - Class A?

Latest CYTH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.